Therapeutic area

Skin and subcutaneous tissue disorders – page 70

843 clinical trials
269 recruiting
353 conditions
25 countries

Clinical trials in Skin and subcutaneous tissue disorders

843 trials across Europe, recruiting first

Click a country to filter the trials

Quick filters

843 clinical trials

Systemic scleroderma

Not recruiting

Registered drugNo placebo

Study on the Effectiveness of Nintedanib and Tocilizumab for Patients with Systemic Sclerosis and Interstitial Lung Disease

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Nintedanib
Sponsor:Narodowy Instytut Geriatrii Reumatologii I Rehabilitacji Im Prof. Dr Hab. Med. Eleonory Reicher

Contact Research Centre

Thermal burn

Not recruiting

InvestigationalNo placebo

Study on the Safety and Effectiveness of EHSG-KF for Treating Deep Dermal and Full Thickness Burns in Children

InvestigationalNo placebo

Italy

Participants:0–17 years
Substances:Bilayer Engineered Collagen Hydrogel-Based Skin Graft Composed Of Autologous Keratinocytes And Fibroblasts
Sponsor:Cutiss AG

Contact Research Centre

Hodgkin's disease+6

Not recruiting

Registered drugNo placebo

Study of Cobolimab and Dostarlimab for Children and Young Adults with Newly Diagnosed or Relapsed/Refractory Tumors

Registered drugNo placebo

Czechia

Participants:0–17 years · 18–64 years
Substances:Cobolimab
Sponsor:Glaxosmithkline Research & Development Limited

Contact Research Centre

Systemic lupus erythematosus

Not recruiting

Investigational

Study on the Effects of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Cenerimod
Sponsor:Viatris Innovation GmbH

Contact Research Centre

Dermatitis atopic

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Upadacitinib and Dupilumab for Children Aged 2 to 12 with Moderate to Severe Atopic Dermatitis

Registered drugNo placebo

Austria

Participants:0–17 years
Substances:Dupilumab
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Metastatic malignant melanoma

Not recruiting

Registered drugNo placebo

Study of Tucidinostat and Nivolumab for Patients with Advanced Melanoma Not Treated with PD-1 or PD-L1 Inhibitors

Registered drugNo placebo

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:Nivolumab
Sponsor:Huyabio International LLC

Contact Research Centre

Ataxia telangiectasia

Not recruiting

InvestigationalNo placebo

Study on the Safety and Effects of EryDex with Dexamethasone Sodium Phosphate for Patients with Ataxia Telangiectasia

InvestigationalNo placebo

Denmark

Participants:0–17 years · 18–64 years
Substances:Dexamethasone Sodium Phosphate
Sponsor:Quince Therapeutics S.p.A.

Contact Research Centre

Pemphigoid

Not recruiting

Investigational

Study on Long-term Safety and Effects of Efgartigimod PH20 SC for Adults with Bullous Pemphigoid

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Efgartigimod Alfa
Sponsor:Argenx

Contact Research Centre

Dermatitis

Not recruiting

Registered drugNo placebo

Study on Dupilumab for Treating Nummular Eczema in Patients

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Dupilumab
Sponsor:Klinikum der Technischen Universitaet Muenchen (TUM Klinikum)

Contact Research Centre

Systemic lupus erythematosus

Not recruiting

Investigational

Study on the Effectiveness and Safety of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus

Investigational

Czechia

Participants:18–64 years · 65+ years
Substances:Cenerimod
Sponsor:Viatris Innovation GmbH

Contact Research Centre

Pseudoxanthoma elasticum

Not recruiting

InvestigationalNo placebo

Study on Preventing Arterial Calcification in Young Patients with Pseudoxanthoma Elasticum Using Etidronate

InvestigationalNo placebo

The Netherlands

Participants:18–64 years
Substances:Etidronate Disodium
Sponsor:Universitair Medisch Centrum Utrecht

Contact Research Centre

Thermal burn

Not recruiting

InvestigationalNo placebo

Study on EHSG-KF for Treating Partial Deep Dermal and Full Thickness Burns in Adults and Adolescents

InvestigationalNo placebo

The Netherlands

Participants:0–17 years · 18–64 years · 65+ years
Substances:Bilayer Engineered Collagen Hydrogel-Based Skin Graft Composed Of Autologous Keratinocytes And Fibroblasts
Sponsor:Cutiss AG

Contact Research Centre

Substances studied in this area

The therapies tested most often in Skin and subcutaneous tissue disorders trials.

Pembrolizumab57 clinical trials Nivolumab33 clinical trials Sodium Chloride22 clinical trials Deucravacitinib19 clinical trials Cemiplimab18 clinical trials Upadacitinib17 clinical trials Ipilimumab15 clinical trials Rituximab13 clinical trials Cyclophosphamide12 clinical trials

Skin and subcutaneous tissue disorders – page 70

Conditions in this area

Clinical trials in Skin and subcutaneous tissue disorders

843 clinical trials

Systemic scleroderma

Study on the Effectiveness of Nintedanib and Tocilizumab for Patients with Systemic Sclerosis and Interstitial Lung Disease

Thermal burn

Study on the Safety and Effectiveness of EHSG-KF for Treating Deep Dermal and Full Thickness Burns in Children

Hodgkin's disease+6

Study of Cobolimab and Dostarlimab for Children and Young Adults with Newly Diagnosed or Relapsed/Refractory Tumors

Systemic lupus erythematosus

Study on the Effects of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus

Dermatitis atopic

Study on the Safety and Effectiveness of Upadacitinib and Dupilumab for Children Aged 2 to 12 with Moderate to Severe Atopic Dermatitis

Metastatic malignant melanoma

Study of Tucidinostat and Nivolumab for Patients with Advanced Melanoma Not Treated with PD-1 or PD-L1 Inhibitors

Ataxia telangiectasia

Study on the Safety and Effects of EryDex with Dexamethasone Sodium Phosphate for Patients with Ataxia Telangiectasia

Pemphigoid

Study on Long-term Safety and Effects of Efgartigimod PH20 SC for Adults with Bullous Pemphigoid

Dermatitis

Study on Dupilumab for Treating Nummular Eczema in Patients

Systemic lupus erythematosus

Study on the Effectiveness and Safety of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus

Pseudoxanthoma elasticum

Study on Preventing Arterial Calcification in Young Patients with Pseudoxanthoma Elasticum Using Etidronate

Thermal burn

Study on EHSG-KF for Treating Partial Deep Dermal and Full Thickness Burns in Adults and Adolescents

Filter the trials

Substances studied in this area

Prefer not to search? Our Concierge searches the trials for you.